CCDC134, a novel secretory protein, inhibits activation of ERK and JNK, but not p38 MAPK

被引:25
|
作者
Huang, J. [1 ,2 ]
Shi, T. [1 ,2 ,3 ]
Ma, T. [1 ,2 ]
Zhang, Y. [1 ,2 ]
Ma, X. [1 ,2 ]
Lu, Y. [3 ]
Song, Q. [1 ,2 ]
Liu, W. [1 ,2 ]
Ma, D. [1 ,2 ,3 ]
Qiu, X. [1 ,2 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Lab Med Immunol, Beijing 100871, Peoples R China
[2] Peking Univ, Human Dis Gen Ctr, Beijing 100083, Peoples R China
[3] Chinese Natl Human Genome Ctr, Beijing, Peoples R China
关键词
CCDC134; secretory protein; inhibit; Elk1; MAPK pathway;
D O I
10.1007/s00018-007-7448-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we report a novel gene, CCDC134 (coiled-coil domain containing 134), that encodes a secretory protein that can inhibit the MAPK pathway as a novel human MAPK-regulating protein. The CCDC134 mRNA contains 1280 nucleotides, encoding a protein of 229 amino acids. CCDC134 is a classical secretory protein. Expression profile analysis by Northern blot, RT-PCR, immunohistochemistry and Western blot reveals that CCDC134 is widely expressed in normal adult tissues, tumor tissues and cell lines. Functional investigation reveals that overexpression of CCDC134 and its purified protein significantly inhibit transcriptional activity of Elk1 and phosphorylation of Erk and JNK/SAPK but not p38 MAPK. Conversely, specific siRNA against CCDC134 activates Elk1 transcriptional activity and promotes Erk and JNK/SAPK phosphorylation. These results clearly indicate that CCDC134 is a novel member of the secretory family and down-regulates the Raf-1/MEK/ERK and JNK/ SAPK pathways.
引用
收藏
页码:338 / 349
页数:12
相关论文
共 50 条
  • [1] CCDC134, a novel secretory protein, inhibits activation of ERK and JNK, but not p38 MAPK
    J. Huang
    T. Shi
    T. Ma
    Y. Zhang
    X. Ma
    Y. Lu
    Q. Song
    W. Liu
    D. Ma
    X. Qiu
    [J]. Cellular and Molecular Life Sciences, 2008, 65 : 338 - 349
  • [2] A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging
    Alessio Lanna
    Daniel C O Gomes
    Bojana Muller-Durovic
    Thomas McDonnell
    David Escors
    Derek W Gilroy
    Jun Hee Lee
    Michael Karin
    Arne N Akbar
    [J]. Nature Immunology, 2017, 18 : 354 - 363
  • [3] Activation of astrocytes by albumin is mediated by p38 MAPK and ERK, but not JNK, -dependent pathways
    Ralay-Ranaivo, H.
    Wainwright, M.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S261 - S261
  • [4] Activation of MAPK/ERK and MAPK/P38 is essential for proinflammatory response by Chlamydia trachomatis
    Cheng Wen
    Chen Fan
    Yu Ping
    Zhong Guang-Ming
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2008, 35 (01) : 56 - 62
  • [5] Axon regeneration requires coordinate activation of p38 and JNK MAPK pathways
    Nix, Paola
    Hisamoto, Naoki
    Matsumoto, Kunihiro
    Bastiani, Michael
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (26) : 10738 - 10743
  • [6] Differential activation of ERK, P38, and JNK MAPK by NOC/OFQ in the potentiation of prostaglandin cerebrovasoconstriction after brain injury
    Armstead, WM
    [J]. JOURNAL OF NEUROTRAUMA, 2005, 22 (10) : 1182 - 1182
  • [7] Activation of Nav1.7Na+ channel phosphorylates ERK and p38 MAPK, but not JNK, in adrenal chromaffin cells
    Miyazaki, Satoshi
    Nemoto, Takayuki
    Kanai, Tasuku
    Yanagita, Toshihiko
    Wada, Akihiko
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 202P - 202P
  • [8] A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging
    Lanna, Alessio
    Gomes, Daniel C. O.
    Muller-Durovic, Bojana
    McDonnell, Thomas
    Escors, David
    Gilroy, Derek W.
    Lee, Jun Hee
    Karin, Michael
    Akbar, Arne N.
    [J]. NATURE IMMUNOLOGY, 2017, 18 (03) : 354 - 363
  • [9] Notoginsenoside Rb1 inhibits activation of ERK and p38 MAPK pathways induced by hypoxia and hypercapnia
    Qiu, Xiaoxiao
    Zheng, Mengxiao
    Song, Dong
    Huang, Linjing
    Tang, Lanlan
    Ying, Lei
    Wang, Wantie
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (06) : 2455 - 2461
  • [10] Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation and Suppresses Inflammatory Pain
    Yang, Yang
    Zhou, Wei
    Xu, Xiuqi
    Ge, Xianxiu
    Wang, Fei
    Zhang, Guang-Qin
    Miao, Lin
    Deng, Xueting
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 12